Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Allen Kaplan

Showing results (11-20 of 32) with videos related to

Pageof 4
Sort By:
Archives of Internal Medicine|July 27, 2005
Incidence and characteristics of angioedema associated with enalaprilJohn B Kostis, Harold J Kim, James Rusnak, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|August 3, 2010
Development of a daily diary for patients with chronic idiopathic urticariaSusan D Mathias, Stephen C Dreskin, Allen Kaplan, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|April 10, 2017
Importance of angioedema-free days in patients with chronic idiopathic or spontaneous urticariaJames L Zazzali, Allen Kaplan, Marcus Maurer, et al.
Molecular Immunology|January 20, 2020
sgp120 and the contact system in hereditary angioedema: A diagnostic tool in HAE with normal C1 inhibitorBlas Larrauri, C Garren Hester, Haixiang Jiang, et al.
Pediatric Neurology|November 6, 2013
A review of childhood and adolescent craniopharyngiomas with particular attention to hypothalamic obesityAmy Rosenfeld, Daniel Arrington, Jeffrey Miller, et al.
The Journal of Allergy and Clinical Immunology|November 15, 2017
The XTEND-CIU study: Long-term use of omalizumab in chronic idiopathic urticariaMarcus Maurer, Allen Kaplan, Karin Rosén, et al.
Molecular Immunology|June 21, 2021
Analysis of cold activation of the contact system in hereditary angioedema with normal C1 inhibitorBlas Larrauri, C Garren Hester, Haixiang Jiang, et al.
Plos One|February 8, 2013
Hereditary angioedema attacks resolve faster and are shorter after early icatibant treatmentMarcus Maurer, Werner Aberer, Laurence Bouillet, et al.
The Journal of Allergy and Clinical Immunology|July 19, 2011
A randomized, placebo-controlled, dose-ranging study of single-dose omalizumab in patients with H1-antihistamine-refractory chronic idiopathic urticariaSarbjit Saini, Karin E Rosen, Hsin-Ju Hsieh, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|July 18, 2016
Angioedema in the omalizumab chronic idiopathic/spontaneous urticaria pivotal studiesJames L Zazzali, Allen Kaplan, Marcus Maurer, et al.
Pageof 4

Showing results (11-20 of 32) with videos related to

Sort By:
Pageof 4
Archives of Internal Medicine|July 27, 2005
Incidence and characteristics of angioedema associated with enalaprilJohn B Kostis, Harold J Kim, James Rusnak, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|August 3, 2010
Development of a daily diary for patients with chronic idiopathic urticariaSusan D Mathias, Stephen C Dreskin, Allen Kaplan, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|April 10, 2017
Importance of angioedema-free days in patients with chronic idiopathic or spontaneous urticariaJames L Zazzali, Allen Kaplan, Marcus Maurer, et al.
Molecular Immunology|January 20, 2020
sgp120 and the contact system in hereditary angioedema: A diagnostic tool in HAE with normal C1 inhibitorBlas Larrauri, C Garren Hester, Haixiang Jiang, et al.
Pediatric Neurology|November 6, 2013
A review of childhood and adolescent craniopharyngiomas with particular attention to hypothalamic obesityAmy Rosenfeld, Daniel Arrington, Jeffrey Miller, et al.
The Journal of Allergy and Clinical Immunology|November 15, 2017
The XTEND-CIU study: Long-term use of omalizumab in chronic idiopathic urticariaMarcus Maurer, Allen Kaplan, Karin Rosén, et al.
Molecular Immunology|June 21, 2021
Analysis of cold activation of the contact system in hereditary angioedema with normal C1 inhibitorBlas Larrauri, C Garren Hester, Haixiang Jiang, et al.
Plos One|February 8, 2013
Hereditary angioedema attacks resolve faster and are shorter after early icatibant treatmentMarcus Maurer, Werner Aberer, Laurence Bouillet, et al.
The Journal of Allergy and Clinical Immunology|July 19, 2011
A randomized, placebo-controlled, dose-ranging study of single-dose omalizumab in patients with H1-antihistamine-refractory chronic idiopathic urticariaSarbjit Saini, Karin E Rosen, Hsin-Ju Hsieh, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|July 18, 2016
Angioedema in the omalizumab chronic idiopathic/spontaneous urticaria pivotal studiesJames L Zazzali, Allen Kaplan, Marcus Maurer, et al.
Pageof 4